# FLOT3 (NCT00849615)

> Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00849615
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Krankenhaus Nordwest
- Conditions: Gastric Cancer; Adenocarcinoma of the Esophagogastric Junction
- Interventions: Docetaxel; 5-Fluorouracil; Oxaliplatin; folinic acid
- Enrollment: 252
- Primary outcome: overall survival

## Commentary we found

- Podcasts: 4
- X threads: 4

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=flot3-nct00849615

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00849615", "email": "<work email>"}; the inbox owner confirms by the emailed link.